You have 9 free searches left this month | for more free features.

defactinib

Showing 1 - 13 of 13

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glioblastoma, Recurrent Glioblastoma Trial in Atlanta (Avutometinib, Biospecimen Collection, Defactinib)

Not yet recruiting
  • Glioblastoma
  • Recurrent Glioblastoma
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Mar 22, 2023

Thyroid Cancer Trial in United States (Avutometinib, Defactinib)

Recruiting
  • Thyroid Cancer
  • Basking Ridge, New Jersey
  • +6 more
Aug 17, 2023

Mesonephric Gynecologic Cancer Trial in United States (VS-6766, Defactinib)

Recruiting
  • Mesonephric Gynecologic Cancer
  • Basking Ridge, New Jersey
  • +6 more
Mar 15, 2023

MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Sydney (Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET,

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET
  • Defactinib
  • Sydney, New South Wales, Australia
  • +3 more
Jan 12, 2023

Pancreas Cancer, Cancer of the Pancreas, Pancreas Adenocarcinoma Trial in Saint Louis (device, drug, procedure)

Recruiting
  • Pancreas Cancer
  • +2 more
  • MR-guided stereotactic body radiation therapy
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 29, 2023

Advanced Solid Tumors, Solid Tumors, Pancreatic Cancer Trial in Rochester, Saint Louis (Defactinib, Pembrolizumab, Gemcitabine)

Completed
  • Advanced Solid Tumors
  • +2 more
  • Defactinib
  • +2 more
  • Rochester, Minnesota
  • +1 more
Jul 18, 2021

NSCLC, Low Grade Serous Ovarian Cancer, Endometrioid Carcinoma Trial in United Kingdom (VS-6766, Defactinib)

Recruiting
  • NSCLC
  • +3 more
  • Manchester, Greater Manchester, United Kingdom
  • +4 more
Mar 18, 2022

Malignant Pleural Mesothelioma Trial in Boston (Pembrolizumab, Defactinib)

Withdrawn
  • Malignant Pleural Mesothelioma
  • Boston, Massachusetts
  • +1 more
Nov 16, 2020

Carcinoma, Non-small-cell Lung, Mesothelioma, Pancreatic Tumors Trial in United Kingdom (Defactinib, Pembrolizumab)

Unknown status
  • Carcinoma, Non-small-cell Lung
  • +2 more
  • Belfast, United Kingdom
  • +4 more
Mar 16, 2018

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Healthy Subjects Trial (defactinib)

Completed
  • Healthy Subjects
  • defactinib
  • (no location specified)
Jan 26, 2017

Ovarian Cancer Trial in Sarasota, Oklahoma City, Nashville (defactinib, Paclitaxel)

Completed
  • Ovarian Cancer
  • Sarasota, Florida
  • +2 more
May 15, 2017

Non Hematologic Cancers Trial in Osaka (Defactinib)

Completed
  • Non Hematologic Cancers
  • Defactinib
  • Osaka, Japan
    Kinki University Hospital
Jan 26, 2017